NASDAQ:DOX - Amdocs Stock Price, Price Target & More

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs announced a quarterly dividend on Thursday, May 10th. Stockholders of record on Friday, June 29th will be given a dividend of $0.25 per share on Friday, July 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend is Thursday, June 28th. View Amdocs' Dividend History.

Amdocs announced that its board has authorized a stock repurchase program on Thursday, November 9th 2017, which authorizes the company to buyback $800,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its stock is undervalued.

Amdocs Limited (NASDAQ:DOX) issued its earnings results on Thursday, May, 10th. The technology company reported $0.95 EPS for the quarter, hitting the consensus estimate of $0.95. The technology company had revenue of $992.34 million for the quarter, compared to analyst estimates of $980.59 million. Amdocs had a net margin of 11.36% and a return on equity of 15.07%. The company's revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.94 EPS. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Amdocs.

Amdocs issued an update on its third quarter earnings guidance on Thursday, May, 10th. The company provided earnings per share guidance of $1.00-1.06 for the period, compared to the Thomson Reuters consensus estimate of $1.01. The company issued revenue guidance of $990-1030 million, compared to the consensus revenue estimate of $1.00 billion.

6 equities research analysts have issued 12 month target prices for Amdocs' shares. Their forecasts range from $60.20 to $77.00. On average, they expect Amdocs' share price to reach $69.24 in the next twelve months. This suggests a possible upside of 1.6% from the stock's current price. View Analyst Ratings for Amdocs.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Amdocs include Wipro (WIT), NTT DATA Corp/ADR (NTDTY), Verisign (VRSN), Obic (OBIIF), EPAM Systems (EPAM), Aspen Technology (AZPN), GEMALTO NV/S (GTOMY), Zscaler (ZS), Sogou (SOGO), Syntel (SYNT), Callidus Software (CALD), Virtusa (VRTU), Luxoft (LXFT), PROS (PRO) and Perficient (PRFT).

News stories about DOX stock have trended somewhat positive this week, according to Accern Sentiment. The research group scores the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Amdocs earned a news sentiment score of 0.14 on Accern's scale. They also gave press coverage about the technology company an impact score of 46.21 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Amdocs' stock is owned by a number of of retail and institutional investors. Top institutional investors include Manning & Napier Group LLC (1.33%), Bank of Montreal Can (0.67%), Fisher Asset Management LLC (0.14%), Nisa Investment Advisors LLC (0.04%), State of Alaska Department of Revenue (0.03%) and Amalgamated Bank (0.01%). View Institutional Ownership Trends for Amdocs.

DOX stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Fisher Asset Management LLC, World Asset Management Inc and Atria Investments LLC. View Insider Buying and Selling for Amdocs.

DOX stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, State of Alaska Department of Revenue, Hartford Investment Management Co., CENTRAL TRUST Co, Nisa Investment Advisors LLC and Amalgamated Bank. View Insider Buying and Selling for Amdocs.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $68.12.

Amdocs has a market capitalization of $9.81 billion and generates $3.87 billion in revenue each year. The technology company earns $436.82 million in net income (profit) each year or $3.55 on an earnings per share basis. Amdocs employs 24,670 workers across the globe.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]